|
gptkbp:instanceOf
|
gptkb:antibiotic
|
|
gptkbp:activeIngredient
|
piperacillin
tazobactam
|
|
gptkbp:approvalYear
|
1993
|
|
gptkbp:ATCCode
|
J01CR05
|
|
gptkbp:contraindication
|
hypersensitivity to penicillins
|
|
gptkbp:drugClass
|
beta-lactamase inhibitor combination
penicillin antibiotic
|
|
gptkbp:eliminationHalfLife
|
0.7-1.2 hours
|
|
gptkbp:excretion
|
renal
|
|
gptkbp:form
|
powder for solution for injection
|
|
gptkbp:genericName
|
gptkb:piperacillin/tazobactam
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Zosyn
|
|
gptkbp:indication
|
gptkb:pneumonia
gptkb:Bacteria
urinary tract infection
intra-abdominal infection
skin and soft tissue infection
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Pfizer
|
|
gptkbp:mechanismOfAction
|
inhibits bacterial cell wall synthesis
beta-lactamase inhibitor
|
|
gptkbp:pregnancyCategory
|
B (US)
|
|
gptkbp:routeOfAdministration
|
intravenous
|
|
gptkbp:sideEffect
|
nausea
diarrhea
allergic reaction
rash
|
|
gptkbp:spectrumOfActivity
|
broad-spectrum
|
|
gptkbp:tradenameInEurope
|
gptkb:Tazocin
|
|
gptkbp:tradenameInUS
|
gptkb:Zosyn
|
|
gptkbp:usedIn
|
gptkb:hospital
|
|
gptkbp:bfsParent
|
gptkb:Wyeth
|
|
gptkbp:bfsLayer
|
5
|